MAR 08, 2018 12:32 PM PST

How does brain cancer escape the immune system?

WRITTEN BY: Kara Marker

One of the most lethal forms of brain cancer owes most of its deadliness to its evasion of the immune system - a nasty trick that prevents T cells and other immune defenses from doing their job. In a new study from Brigham and Women’s Hospital, scientists learn a little bit more about how tumors play hide-and-seek with the immune system, potentially uncovering new ways to detect and treat brain cancer.

An MRI of a 15-year-old glioblastoma patient. Credit: Christaras A

Glioblastoma is a type of cancer that develops from astrocytes, supportive cells that live in the brain. This type of brain cancer is very malignant; tumor cells multiply quickly and tap several blood vessels for a steady supply of oxygen and nutrients. Glioblastoma tumors are usually found in the cerebral hemispheres of the brain and make up 15.4 percent of all primary brain tumors. Likelihood of developing glioblastoma increases with age, especially for men. The median survival for adults with glioblastoma is two or three years.

The new study focuses on extracellular vesicles (EVs), which glioblastoma tumor cells, like other cells, produce. EVs are known for their role in intercellular communication; cells often discard EVs as they undergo apoptosis, or programmed cell death. But in the case of brain cancer, tumor cells produce EVs to suppress the immune response.

EVs help tumors do so by providing a protein called PDL-1, which contributes to T cell deactivation. Cancer cells also “hijack” immune checkpoints to prevent the immune system from mounting an anti-cancer attack. EVs also contain DNA and RNA that help tumor cells not just survive, but flourish in the human body.

"This is the first time that anyone has observed that immune checkpoints can operate through extracellular vesicles and not just through the cell surface," explained co-corresponding author Sean Lawler, PhD. "This is a new concept, suggesting that these vesicles can work more distantly from the tumor cells."

In the study, researchers also found traces of DNA from EVs in the blood of glioblastoma patients, indicating EVs as a potential biomarker for the disease.

Researchers also analyzed blood samples from both healthy people and from glioblastoma patients. Out of 21 samples, researchers found elevated PDL-1 DNA in isolated EVs in 14 samples. The more PDL-1 DNA, the largest the tumors tended to be.

The findings of this study indicate a new opportunity for scientists to use EVs as a biomarker for glioblastoma, but studies with a larger group of participants are needed to confirm the significance of the results.

The present study was published in the journal Science Advances.

Sources: American Brain Tumor Association, Nature Reviews Drug Discovery, Brigham and Women’s Hospital

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
AUG 25, 2020
Immunology
Targeting Checkpoint Molecule Could Mean Checkmate for Cancer
AUG 25, 2020
Targeting Checkpoint Molecule Could Mean Checkmate for Cancer
In a new study published in Cell, researchers have identified a metabolic enzyme that could have powerful tumor-killing ...
SEP 23, 2020
Immunology
Gene That Fuels Antibody Factories Discovered
SEP 23, 2020
Gene That Fuels Antibody Factories Discovered
Antibodies are Y-shaped proteins that play a central role in the immune system’s arsenal of germ-busting weapons. ...
NOV 04, 2020
Coronavirus
Damaging Antibodies Can Lead to Blood Clots in COVID-19 Patients
NOV 04, 2020
Damaging Antibodies Can Lead to Blood Clots in COVID-19 Patients
COVID-19, the illness caused by the pandemic virus SARS-CoV-2, is known to cause blood clots all over the body in some p ...
NOV 12, 2020
Immunology
Anti-bodies against a sugar present in meat and dairy products can increase the risk of Colorectal Cancer
NOV 12, 2020
Anti-bodies against a sugar present in meat and dairy products can increase the risk of Colorectal Cancer
Nutrition is essential to health; what we eat in our daily diet affects our overall health condition and what diseases w ...
NOV 12, 2020
Health & Medicine
Measles Cases and Deaths Surge Worldwide
NOV 12, 2020
Measles Cases and Deaths Surge Worldwide
Today, the World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (CDC) released a stat ...
NOV 10, 2020
Neuroscience
Nanoparticles Pass the Blood-Brain Barrier in Zebrafish
NOV 10, 2020
Nanoparticles Pass the Blood-Brain Barrier in Zebrafish
Video:  Explains the challenges of delivering medicine to the brain, and possibly tools to pass the blood-brain bar ...
Loading Comments...